Bcl-xL is a new prognostic factor in human hepatocellular carcinoma

被引：0
|
作者：
Watanabe, J [1 ]
机构：
[1] Ehime Univ, Sch Med, Dept Durg 1, Matsuyama, Ehime 790, Japan
来源：
PROCEEDINGS OF THE XXXIX CONGRESS OF THE EUROPEAN SOCIETY FOR SURGICAL RESEARCH | 2004年
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：217 / 218
页数：2
相关论文
共 50 条
  • [21] T-cell Factor-4 isoforms directly regulate Bcl-xL expression in human hepatocellular carcinoma (HCC) cells
    Koga, Hironori
    Kim, Miran
    Nakamura, Anna
    Yano, Hirohisa
    Nakamura, Toru
    Ueno, Takato
    Torimura, Takuji
    Wands, Jack R.
    Sata, Michio
    HEPATOLOGY, 2013, 58 : 1088A - 1088A
  • [22] A Novel Therapeutic Combination Sequentially Targeting Aurora B and Bcl-xL in Hepatocellular Carcinoma
    Matsunaga, Hiroko
    Tanaka, Shinji
    Aihara, Arihiro
    Ogawa, Kousuke
    Matsumura, Satoshi
    Ban, Daisuke
    Ochiai, Takanori
    Irie, Takumi
    Kudo, Atsushi
    Nakamura, Noriaki
    Arii, Shigeki
    Tanabe, Minoru
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (09) : 3079 - 3086
  • [23] Re: Prognostic significance of Bcl-xL gene expression in human colorectal cancer
    Wiwanitkit, Viroj
    ACTA HISTOCHEMICA, 2012, 114 (02) : 182 - 182
  • [24] A Novel Therapeutic Combination Sequentially Targeting Aurora B and Bcl-xL in Hepatocellular Carcinoma
    Hiroko Matsunaga
    Shinji Tanaka
    Arihiro Aihara
    Kousuke Ogawa
    Satoshi Matsumura
    Daisuke Ban
    Takanori Ochiai
    Takumi Irie
    Atsushi Kudo
    Noriaki Nakamura
    Shigeki Arii
    Minoru Tanabe
    Annals of Surgical Oncology, 2015, 22 : 3079 - 3086
  • [25] Inhibition of p53-mediated apoptosis by Bcl-xL endogenously expressed in human hepatocellular carcinoma.
    Takehara, T
    Friedman, SL
    Takahashi, H
    GASTROENTEROLOGY, 2000, 118 (04) : A923 - A923
  • [26] MicroRNA-377 Downregulates Bcl-xL and Increases Apoptosis in Hepatocellular Carcinoma Cells
    Ge, Hongyan
    Zou, Di
    Wang, Yingshu
    Jiang, Hao
    Wang, Liping
    ONCOLOGY RESEARCH, 2017, 25 (01) : 29 - 34
  • [27] Decrease of Bcl-xL/Bcl-2-associated death promoter in hepatocellular carcinoma indicates poor prognosis
    Hu, Wen
    Fu, Jia
    Lu, Shi-Xun
    Liu, Li-Li
    Luo, Rong-Zhen
    Yun, Jing-Ping
    Zhang, Chris Zhiyi
    AMERICAN JOURNAL OF CANCER RESEARCH, 2015, 5 (05): : 1805 - 1813
  • [28] Effect of bax,bcl-2 and bcl-xL on regulating apoptosis in tissues of normal liver and hepatocellular carcinoma
    Xiao-Zhong Guo Xiao-Dong Shao Min-Pei Liu Jian-Hua Xu Li-Nan Ren Jia-Jun Zhao Hong-Yu Li Di Wang
    World Journal of Gastroenterology, 2002, 8 (06) : 1059 - 1062
  • [29] Effect of bax, bcl-2 and bcl-xL on regulating apoptosis in tissues of normal liver and hepatocellular carcinoma
    Guo, XZ
    Shao, XD
    Liu, MP
    Xu, JH
    Ren, LN
    Zhao, JJ
    Li, HY
    Wang, D
    WORLD JOURNAL OF GASTROENTEROLOGY, 2002, 8 (06) : 1059 - 1062
  • [30] Vasoactive intestinal peptide increases apoptosis of hepatocellular carcinoma by inhibiting the cAMP/Bcl-xL pathway
    Hara, Masaki
    Takeba, Yuko
    Iiri, Taroh
    Ohta, Yuki
    Ootaki, Masanori
    Watanabe, Minoru
    Watanabe, Daiki
    Koizumi, Satoshi
    Otsubo, Takehito
    Matsumoto, Naoki
    CANCER SCIENCE, 2019, 110 (01): : 235 - 244
12345